Actively Recruiting
NextGen - Clinical Implication of Next Generation Sequencing
Led by Wake Forest University Health Sciences · Updated on 2025-12-08
100
Participants Needed
1
Research Sites
341 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Recently more advanced techniques, including Polymerase Chain Reaction (PCR) and Next Generation Sequencing (NGS) are available to detect bacteria in urine based on bacterial genomes. Comparing to traditional culture, these techniques have more sensitivity and could potentially be of a great help in patients with Colony Count of less than 10,000 and more than zero.
CONDITIONS
Official Title
NextGen - Clinical Implication of Next Generation Sequencing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female at least 18 years of age
- Urine culture growth of less than 10,000 Colony-Forming Units (CFU)
- Understanding and acceptance of the need to return for all scheduled follow-up visits
- Able to give informed consent
You will not qualify if you...
- Use of any catheter (Foley, suprapubic, or intermittent)
- Inability to provide clean midstream urine sample
- Antibiotic use within 2 weeks before consent
- Pregnant or planning to conceive
- Incarcerated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Wake Forest Health Sciences
Winston-Salem, North Carolina, United States, 27157
Actively Recruiting
Research Team
M
Majid Mirzazadeh, MD
CONTACT
S
Sachin N Vyas, MS, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here